Approvals and regulation
Regulatory approvals, regulation of AI medical devices, and health policy decisions.
Viewpoint
November 2026 · 12
FDA grants Breakthrough Device Designation to Cleo Skin AI pathology toolmedtech companyThe designation means faster dialogue with the regulator, but market authorisation still requires clinical evidence.doctorIt is an early sign of AI support becoming available in dermatological pathology.Evident Vascular receives FDA approval for AI-powered IVUS imaging platformdoctorInterventional cardiologists will be able to use AI-supported IVUS imaging during procedures.medtech companyThe approval shows that AI can also be authorised in invasive imaging devices.FDA clears Neurotronics' AI-based sleep analysis softwaredoctorAutomating the analysis used in sleep diagnostics may partly replace manual scoring, but clinical validation is still required.medtech companyAnother 510(k)-type reference for the regulatory pathway of AI-based software products.FDA classifies digital cervical cytology slide imaging systems that use AI algorithmsmedtech companyThe classification determines the regulatory pathway and the evidence required to bring cytology AI tools to market.doctorFor pathologists and cytologists, regulated use of AI-assisted screening reads moves closer.Study of 3,011 FDA warning letters finds seven citing AI, including earliest CDER letterpharmaceuticalsThe use of AI in manufacturing must be documented and validated within the quality assurance system, as the regulator already refers to it.medtech companyCompliance preparation should include validating AI tools.Stakeholders offer competing views on how FDA should regulate generative AI in medtechmedtech companyApproval strategies for generative AI products must be adjusted as the FDA's approach evolves.health policyIn shaping the regulatory framework, the challenge is balancing the differing interests of stakeholders.Senate draft bill seeks input on health AI oversight as FDA and CMS look to work with stateshealth policyCoordinating federal and state regulation is the key issue for the coming period.medtech companyMulti-level oversight may bring differing requirements, so the legislative process must be followed.AMA outlines governance framework for agentic AI in clinical caredoctorThe professional body's position offers guidance on the level of oversight needed when using autonomously acting AI systems.hospital managerIt provides a reference framework for institutional governance policies.All 53 member states of WHO's European Region unanimously adopt roadmap for AI in health carehealth policyNational AI strategies and governance frameworks will need to be aligned with the roadmap, so it is worth mapping the gaps now.hospital managerInstitutional AI governance (accountability, validation, data management) will likely be measured against this framework.health ITProcurement and compliance requirements may tighten as they are derived from the roadmap.AI vendors and health systems may share liability with physicians for clinical AI, AMA sayshospital managerContracts and deployment processes must set out who bears responsibility when AI tools fail.doctorFollowing or overriding an AI recommendation should be documented, because liability is shared.European Health Data Space opens opportunities for AI, while Georgetown finds gaps in AI health equity guidancehealth policyTogether, the data space and the AI Act set the framework for data sharing and risk management.health ITInteroperability and AI compliance requirements should be built into plans now.Senate draft would let Medicare test paying for AI that performs clinical tasks without real-time physician reviewdoctorA payment model for AI without physician oversight raises questions of professional liability and division of tasks.health policyThe payment model could be the first major state-funded trial of clinical AI autonomy.medtech companyIt could open a reimbursement path for autonomous clinical AI tools.
October 2026 · 48
Government decree on National Institute of Pharmacy monitors medical AI decision-support softwaremedtech companyFor AI and decision-support software entering the Hungarian market, the renewed regulatory competence must be clarified.health ITDevelopers of AI systems should expect regulatory monitoring and data requests.health policyThe restructuring of the authority sets out the domestic institutional framework for AI oversight.FDA and CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settingshealth policyMisaligned state and federal rules could create uncertainty for AI pilots.hospital managerLicensing and payment conditions should be clarified before joining state AI experiments.California tightens rules for health care chatbots under new lawhealth ITCompliance requirements for patient-facing chatbots should be reviewed for operations in California.health policyState-level chatbot regulation could serve as a model for other jurisdictions.Chancellor announces NHS AI innovation funding ahead of the budgethealth policyThe funding signals that AI adoption is a government priority and can serve as a model for funding arguments in Hungary.health ITNHS procurement and pilots are expected to expand.FDA clears Deep Reasoning AI's NeuroDR neurovascular CT angiography softwaredoctorRadiologists and neurologists may gain a new decision-support tool for acute vascular imaging.medtech companyThe 510(k) pathway remains viable for AI imaging software.NICE provisionally backs five AI tools for prostate cancer detection on MRI in the NHSdoctorRadiologists and urologists can expect limited use accompanied by data collection.medtech companyThe interim funding route offers a model for market entry paired with evidence generation.health policyInterim support tied to data collection can address the evidence gap for AI tools.WHO European Region adopts 2026–2033 health AI roadmap; Luxembourg to host officehealth policyThe roadmap is a reference framework for national AI strategies and for metrics of responsible deployment.hospital managerThe roadmap is expected to shape institutional AI governance requirements as well.ATA Action urges FDA to adopt risk-based framework for AI medical devices; policy proposal in the worksmedtech companyThe classification of generative AI devices and the change-management plan should be clarified at an early stage of development.hospital managerInstitutions need to track their device inventory and manufacturers' risk classifications.EU AI Act high-risk rules pushed back to 2 December 2027medtech companyThe compliance timeline can be reworked, but joint planning for MDR and AI Act requirements is still needed.health policyThe delay gives time to build national supervisory capacity.Pennsylvania House passes bill requiring AI disclosure in healthcarehospital managerInstitutions need to identify where they use AI in patient communication or decisions, as it will have to be disclosed.health ITPrepare for the technical implementation of disclosure points such as messages and chatbots.NICE backs interim NHS use of AI to review prostate MRI scansdoctorRadiologists and urologists may work with AI support in MRI reporting, but the final assessment stays with them.hospital managerNHS providers need to prepare for the conditions of the interim rollout, including workflow integration.medtech companyInterim NICE backing is a reference point for AI-based imaging software entering the UK market.Czechia prepares to present its first national AI healthcare strategyhealth policyThe neighbouring country's strategy and its level of radiology AI adoption serve as a benchmark.doctorWidespread trials of AI in radiology are becoming a professional norm in the region.Poland to join HealthAI global regulator network, second EU member to do sohealth policyJoining the network offers regional member states a model to follow for regulatory cooperation on healthcare AI.medtech companyThe international regulatory network may bring approval practices closer together.Karolinska Institutet analysis asks who should decide when medical AI may be updatedmedtech companyOversight questions around updates point to regulatory solutions similar to PCCP-style plans.Abu Dhabi health department signs agreements and publishes AI clinician frameworkhealth policyThe AI clinician framework is an example of regulatory oversight of research into AI medical systems.pharmaceuticalsThe AI drug discovery agreements open up new collaboration opportunities in the Gulf region.FDA clears MRI-based AI for mild cognitive impairment prognosis and Elucid's FFR-IQdoctorNeurologists and cardiologists may gain new AI-based prognostic and functional imaging tools.medtech companyThe 510(k) clearances signal a path for further categories of imaging AI.AHA, AMA, ATA and radiology groups respond to FDA plan for generative AI medical devicesmedtech companyRisk-based classification, PCCPs and manufacturer accountability bear directly on the authorization plans for generative AI products.doctorThe professional bodies' proposals may also shape how clinician responsibility and oversight are divided.hospital managerDiverging FDA and state rules create procurement and compliance risk for generative AI tools.health policyThe conflict between state and federal levels creates an unclear regulatory environment.FDA clears MRI-based AI tool to assess breast cancer recurrence riskdoctorOncologists and radiologists may gain additional prognostic information from MRI to inform treatment decisions.medtech companyThe clearance reinforces the regulatory pathway for prognostic imaging AI.MHRA promises closer FDA cooperation on AI medical devices at AdvaMed; Japan's PMDA shares principlesmedtech companyCloser FDA–MHRA cooperation and the PMDA principles may help companies plan multi-market clearance for AI devices.health policyRegulatory convergence makes it possible to align approval practices.EU launches SCAILED project for health AI innovation; health data space could aid pandemic warninghealth policyThe EHDS could provide the data foundation for AI-supported epidemic surveillance.health ITStandardising data connections is a precondition for a shared data space.AI-generated evidence in drug discovery: reliability, legal risk and FDA compliancepharmaceuticalsAI-generated citations and results must be handled with documented verification before they enter submission materials.SimBioSys receives FDA clearance for AI breast cancer recurrence tooldoctorOncologists and breast surgeons should consider how recurrence-risk prediction could fit into treatment decisions.medtech companyAnother example that prognostic software can also reach FDA clearance, a benchmark for companies' own submissions.hospital managerOncology services should assess whether the tool is needed and what implementing it would cost.Utah approves AI system that prescribes medication without physician oversightdoctorThis is a precedent for handing the prescribing role to AI, so professional chambers will need to take a position on liability.health policyThe model is worth watching as a possible template or a cautionary example in regulating prescribing authority.pharmaceuticalsDirect AI prescribing could also change the access path for prescription-only products.PHTI releases framework to scale high-value clinical AI over administrative useshospital managerProcurement can use criteria that measure clinical value.health policyThe framework could serve as a basis for funding priorities.MHRA sets out how medicines regulation will adapt to the era of AIpharmaceuticalsIn marketing authorisation submissions, it is worth aligning the documentation of AI use with MHRA expectations.health policyThe UK approach can be used for comparison with EU and US regulators.CMS sets voluntary goals for patient-facing AI assistantshealth ITDevelopers of patient portals and assistants may want to consider signing on.health policyVoluntary pledges can be watched as a step ahead of mandatory regulation.AMA proposes governance framework for agentic AI taking on clinical functionsdoctorThe principles of responsibility and authority provide a basis for documenting AI-assisted decisions.hospital managerA starting point for drafting an institutional AI governance policy.health ITWhen designing agentic systems, the requirement of clinical authority is worth taking into account.California bill aims to ensure AI does not bind doctors' decisionsdoctorThe bill would protect clinical decision-making freedom against AI recommendations.health policyIt could serve as a state-level regulatory model for other states.US state lawmakers highlight chatbot bills and AI's impact on mental healthhealth policyState-level chatbot regulation creates a fragmented legal environment.health ITCompanies offering mental health chatbots must follow state requirements.FDA publishes discussion paper on generative AI-enabled medical devicesmedtech companyCompanies should submit comments before the deadline, as the discussion paper lays the groundwork for the future regulatory framework for generative AI devices.health policyThe planned framework could also become a benchmark for regulators in other markets.EU Biotech Act and the MDR–AI Act relationship divide the medtech sectormedtech companyGiven the parallel compliance burdens under the MDR and the AI Act, companies should align their compliance plans with the current proposals.health policyThe dispute over removing patient-safety safeguards is a question to be settled in the legislative process.doctorHow devices are classified and checked determines how far clinicians can rely on them in clinical use.Scarlet raises $50M to build AI-native medical device certificationmedtech companyAI support in the certification process can shorten compliance work, but the quality of the provider needs to be verified.FDA has cleared more than 1,600 AI medical devices; warning letter flags software updatesmedtech companyThe FDA scrutinises change-management documentation for algorithm updates and cloud migrations.doctorBecause radiology AI dominates, experience of using it is greatest in that field.Four US states set different rules on whether AI can call itself a nursemedtech companyProduct names must be checked state by state.AI in regulatory filings and trials: Annovis partners with Weave Bio; Cori Clinical raises $4M seed roundpharmaceuticalsAI has also appeared in preparing regulatory documentation and organising trials.FDA clears first AI test predicting breast cancer risk from a pathology slide; another risk tool available nationwidedoctorPathologists and oncologists may gain access to new risk information based on tissue samples.medtech companyReaching patients directly raises new sales and regulatory questions.Australia's TGA regulates AI-based medical software as a medical devicemedtech companyThe intended purpose of AI software determines whether it counts as a medical device, so this must be clarified before entering the Australian market.Utah lets AI prescribe acne medication without direct physician oversightdoctorTwo physicians' approval is required for the first 100 prescriptions, so the supervisory role remains for now, but part of routine prescribing could shift to AI.health policyUtah's model is a template for the regulatory sandbox and AI prescribing, worth watching because of its relationship with the FDA.hospital managerIt is worth assessing how the reshaping of routine care affects outpatient volumes and liability questions.health ITIntegrating photo-based assessment and prescription issuing raises new vendor and data-handling requirements.UK government accepts all 44 recommendations of national commission on AI in healthcare regulationmedtech companyAI-based devices must stay under continuous oversight after they reach the market, and the company must manage the device's development in line with the regulator.health policyThe new UK framework could serve as a model, so it is worth following the details of the recommendations and the implementation timetable.health ITSuppliers of AI systems used in the NHS should expect changing compliance and monitoring requirements.doctorThe oversight conditions for AI tools used in the NHS are changing, so it is worth following what checks will accompany their clinical use.FDA outlines 2027 AI guidance plans; nurses can comment on generative AI framework until October 19medtech companyDevelopers of generative AI devices need to follow the FDA framework, as it will shape future authorisation expectations.health policyThe FDA's 2027 plans point to the direction of future oversight of AI devices.California law says medicine must be practised by doctors and nurses, not AIdoctorThe law reaffirms that clinical decisions remain the physician's responsibility, even with AI support.hospital managerWhen deploying AI systems, hospitals must ensure that a qualified professional still makes the clinical decision.health policyThe contrast between the Californian and Utah approaches is a reference point for further state regulation.FDA clears AIRS Medical's AI MRI tool for body composition analysismedtech companyThe clearance is another example of the regulatory pathway for AI applications built on MRI imaging.doctorRadiologists may gain a new AI-based body composition analysis option.Lunit's breast imaging AI wins FDA clearance to automatically compare years of mammogramsdoctorAutomating comparison over time could save radiologists time.medtech companyThe clearance shows the regulatory feasibility of features that analyse patient history.A year after California, other states move to ban AI-only insurance denialshealth policyStates copying the California model one by one signals a new direction in regulating insurers' use of AI.doctorRequiring human review could make it easier to challenge insurers' denials.hospital managerInsurers' use of AI in reimbursement and denial processes is worth monitoring.HHS and ARPA-H move to speed up clinical trials with AIpharmaceuticalsImprovements to federal trial infrastructure affect opportunities in trial organisation and data collection.health policyThe joint action by HHS and ARPA-H signals an AI-driven transformation of clinical research.FDA to prioritize guidance on AI and surgical robots next yearmedtech companyMust align AI and robotics product plans with the upcoming guidance.health ITShould watch for new draft guidance on compliance of software-based devices.Newsom vetoes bill protecting nurses who override AI, but signs clinical judgment lawhospital managerHospital executives must set out in internal policy that clinical judgment takes precedence over AI.health policyCalifornia's twin decision may offer a model for other states' regulation.Four ARPA-H initiatives aim to modernize US clinical trialspharmaceuticalsAI-driven modernization of trial processes could change development timelines.health policyThe government programs are instruments for competitiveness against China.
September 2026 · 59
European academies call for stricter rules on AI in healthcare in EASAC–FEAM reporthealth policyShould take the report's recommendations into account in implementing the AI Act and in regulating long-term consequences.doctorShould keep AI safety and liability issues on the professional agenda.hospital managerShould treat AI procurement and deployment as a high-risk system.EU AI Act in healthcare: high-risk rules and deadlines in 2027 and 2028medtech companyMust align MDR/IVDR conformity assessment with the AI Act's August 2028 deadline.pharmaceuticalsShould assess which of its internal AI tools fall into the high-risk category.hospital managerShould prepare for deployer obligations for triage AI and other systems under Annex III.health ITShould schedule documentation and compliance work around the deadlines.ANA adds AI to nursing scope and standards; NCSBN launches surveyhospital managerHospital executives must align nurses' AI-use policies with the ANA standards.WHO warns health AI research is outpacing ethics oversighthealth policyEthics committee oversight of AI research needs to be strengthened.doctorClinicians taking part in research must check ethical compliance more closely.AI recommendations could help Britain carve its own path on medical device regulationmedtech companyCompanies entering the UK market must align with the distinct British regulatory route.health policyDifferences between the British and EU regulatory paths need to be weighed.FDA explores competency-based path for generative AI-enabled medical devicesmedtech companyShould comment on the framework and prepare for stricter evidence of intended use and clinical risk.health ITMust align generative AI CDS development with the lifecycle-based approach.health policyShould follow how the competency-based approach, modelled on the way physicians are assessed, develops.AI drug discovery tools carry risky contract terms as USPTO inventorship rules changepharmaceuticalsAI vendor contracts and the handling of inventorship rights must undergo legal review.FDA clears AI devices: Tempus ECG tool, kidney stone surgery robot, CapsoCam featuredoctorNew ECG, endoscopy and surgical AI tools are becoming clinically available.medtech companyThe clearances are model cases for AI devices going through the FDA pathway.New rules for AI-generated real-world evidence in Canadian health technology assessmentspharmaceuticalsAI-generated RWE in Canadian HTA submissions must be submitted under the new rules.New EU product liability rules extend to innovative medical devices and AImedtech companyMust reassess liability exposure and the provability of its documentation.health ITLogging and explainability of AI system operation gain legal significance.Commission defends AI medical device simplification plan after German warning; Hungarian analysis on classificationmedtech companyThe planned simplification and classification by intended purpose will determine the regulatory route for AI software, so companies should map the expected pathway now.health policyThe debate between patient protection and simplification will shape the next stage of EU regulation.New procurement guide urges hospitals and payers to weigh AI's environmental impacthospital managerEnvironmental criteria can be added to AI procurement requirements.health ITVendors should be asked for data on energy and resource use.UK regulators and health bodies move on healthcare AI: commission recommendations, 'L-plate' model, joint guidancedoctorProfessional colleges and NHS guidance set out expectations for the safe use of AI.health policyJoint regulator guidance and the sandbox approach offer a model for coordinating AI oversight.health ITThe Manchester sandbox gives AI suppliers a chance to test in a real-world environment.a2z Radiology wins FDA clearance for CT AI, adding 10 findings to abdomen-pelvis triagedoctorRadiologists have another cleared AI aid for emergency CT triage.medtech companyThe expanded FDA clearance provides a reference point in the market competition for CT triage products.WHO report calls for stronger ethics oversight of AI-related health researchhealth policyThe remit of ethics committees and the criteria for reviewing AI research should be aligned with the new recommendations.doctorClinical research involving AI should expect stricter ethics review.FDA extends feedback period on generative AI medical device rules and tests language models on radiology reportsmedtech companyThe regulatory framework for generative AI devices is still taking shape, so companies should use the opportunity to comment.health policyThe FDA's experiments point to future methods of evaluating AI.India's drug regulator forms AI expert committeepharmaceuticalsIn Indian clinical trial decisions, expert committee review still counts and AI does not replace it.EU AI Act high-risk deadline: medical devices follow the sector-specific conformity routemedtech companyFor devices that contain AI, the sector-specific conformity process and the high-risk deadline are part of the design.health ITIt is worth requesting suppliers' declarations of conformity.AI use policy template and companion guide published for health departmentshealth policyA ready-made policy template speeds up the development of institutional AI guidelines.FDA order keeps radiology AI under 510(k) premarket reviewmedtech companyRevenue for radiology AI remains tied to premarket clearance, so the 510(k) plan and documentation need to be maintained.doctorCheck the authorization status of radiology AI tools before adopting them.FDA clears RadNet's foundation model-based chest X-ray AI tooldoctorFoundation model-based X-ray AI is a new option to evaluate in the radiology workflow.medtech companyClearance of a foundation model-based tool sets a precedent for similar developments.FDA publishes discussion paper on regulating generative AI-enabled medical devicesmedtech companyThe discussion paper is an opportunity to give feedback, so it is worth submitting expert comments.health policyDevelopments in the regulatory framework for generative AI devices should be followed.Health and social care regulators coordinate their response to AIhealth policyCoordination between regulators may signal more consistent expectations towards providers.Von der Leyen: healthcare AI should be European and must not replace doctorshealth policyAhead of the Commission's November initiatives, it is worth mapping the national position and one's own healthcare AI programmes.health ITThe expectation of a "European" solution may affect vendor and data-storage decisions, so procurement plans should be aligned with it.doctorThe emphasis is that AI will not replace doctors, so for professional chambers, securing the supporting role of these tools is the negotiating position.Connecticut bans AI-based health insurance denials for state employeeshealth policyA state-level AI rule could serve as a model for other states.doctorDoctors can cite the rule against denials that rely on AI.Cognita wins $1.29 million FDA contract to evaluate radiology AImedtech companyThe FDA is developing its methodology for evaluating radiology AI, which may shape future expectations.Third meeting of the Global Initiative on AI for Health heldhealth policyInternational coordination can help align regulatory approaches.Powerful Medical's 'Queen of Hearts' AI ECG model wins FDA De Novo authorizationdoctorA new, authorized AI ECG tool is entering cardiac diagnostics.medtech companyThe De Novo pathway creates a new product category, which serves as a reference for similar devices.FDA weighs changes to clinical trial design, drug development and use of AI in trialspharmaceuticalsChanges to trial-design and AI-use rules may affect development plans, so they are worth tracking.health policyRules on the use of AI in clinical trials could serve as a guide.Legislative moves target use of mental health chatbotshealth policyState-level chatbot regulation is taking shape.health ITProviders offering a mental health chatbot are advised to prepare for compliance.UK commission publishes 44 recommendations on regulating AI in healthcare, from pre-market to lifecyclehealth policyThe staged regulatory model can serve as a template for other countries' frameworks.medtech companyLifecycle-based oversight may foreshadow post-market monitoring obligations.health ITDeployers are likely to face a requirement for continuous performance monitoring.US health officials deploy medical AI as safety concerns persisthealth policyThe tension between state-level deployment pilots and federal oversight is a regulatory risk.doctorThe move toward autonomous AI raises questions of liability and oversight.medtech companyNo generative AI product for mental health has yet been authorized, which is both a market gap and a regulatory risk.Watchdog says patients should be told when NHS uses AI in their carehospital managerPatient-information rules and the flagging of AI use are worth building into the consent process.doctorInforming patients about the use of AI has to be handled in everyday practice.NHS AI procurement should require ethnicity performance data, say calls for race equity focushealth ITProcurement documents must ask suppliers for performance data broken down by ethnic group.health policyAn equity requirement can become a condition of procurement.Radiology accounts for 76% of FDA AI device authorizationsmedtech companyRadiology is the most crowded authorization area, and the FDA list can be used for competitor analysis.doctorRadiologists are the professional group most affected by AI.AMA publishes guidance on ethical questions about health AIdoctorThe AMA guidance is a reference point for the ethical assessment of AI use.AI in life sciences: ten legal considerations for drug discoverypharmaceuticalsThe legal risks of AI use should be addressed in internal compliance checks.FDA's PCCP lets AI devices update without a new clearancemedtech companyA PCCP must be planned early in development, but it does not by itself resolve all AI lifecycle questions.health ITVersion tracking and validation of updating models must also be handled on the hospital side.NHS Resolution issues guidance on scheme coverage and liability for AI usedoctorClinicians should clarify what coverage applies to their own practice when a decision is AI-supported.hospital managerLiability frameworks need to be built into procurement and implementation documentation.Court rules patients have no right to ambient AI recordingsdoctorSet a policy for handling the recordings and for informing the patient.health ITAlign retention and access rules for the recordings with the legal position.Canada: health care AI strategy needs matching oversight as Loblaw launches AI health chathealth policyOversight capacity must be planned alongside the strategy.MHRA and Manchester NHS launch sandbox to test AI and health tech toolsmedtech companyThe sandbox offers real-world testing under regulatory supervision.health ITPilot contracts can start here with regulatory feedback.Federal health officials outline AI plans as clinicians debate riskshealth policyThe federal direction signals future regulatory and funding priorities.UK commission: phased approval and new legislation needed for healthcare AIdoctorExpect new AI tools to enter practice through phased approval, with a narrower scope of use.hospital managerIt is worth aligning AI procurement and rollout processes with the proposed phased model.health ITAsk vendors up front for safety and oversight evidence, as it may become a regulatory requirement.health policyThe report sets out a concrete regulatory plan that can be compared with national and EU approaches.medtech companyCompanies entering the UK market should plan for post-deployment data collection because of the phased approval model.Khosla asks FDA to certify AI that outperforms the median doctor; nurses objectdoctorThe regulatory debate over reshaping the physician's role directly concerns the profession's autonomy.Global effort launched to overhaul regulatory framework for AI medical devicesmedtech companyHarmonisation efforts affect approval strategy across several markets.health policyTaking part in international coordination can shape the national regulatory direction.FDA weighs regulating AI devices like doctors as TEMPO pilot tests generative AImedtech companyThe approval pathway for generative AI devices is taking shape in the TEMPO pilot; it is worth following the participation criteria.doctorIf devices are regulated by a doctor-like standard, questions of liability and oversight may change.health policyThe FDA's direction could set a precedent for other regulators in handling autonomous AI.Hungary plans HUF 35 billion to develop its health and life sciences AI sectorhealth policyThe planned allocation of funds could become a main framework of Hungary's health care AI strategy.health ITTender and development opportunities may open for domestic suppliers.pharmaceuticalsBecause of the life sciences focus, funding of AI-based R&D collaborations is also affected.Powerful Medical's AI heart attack detection model wins FDA approvaldoctorNew, cleared decision support becomes available for ECG assessment in emergency and cardiology settings.medtech companyAnother example of the regulatory pathway for ECG AI.California moves to regulate AI therapy chatbots amid mental health concernshealth policyA state-level precedent for regulating AI therapy tools.health ITCompliance requirements for mental health apps may change.San Francisco supervisors urge Kaiser to limit AI use in mental health servicesdoctorMental health professionals need to clarify which tasks they may hand over to AI in patient care.health policyLocal bodies can also put pressure on providers to limit the use of AI in mental health care.Vara receives world-first CE certification for autonomous AI in breast cancer screeningdoctorRadiologists need to prepare for AI working independently in some screening cases.hospital managerBreast screening programs should consider procuring autonomous AI and redesigning their workflows.medtech companyAutonomous diagnostic AI now has an EU regulatory pathway, which is also a benchmark for competitors.Manchester NHS and MHRA launch AI testing sandbox; MHRA commission publishes findingsmedtech companyThe sandbox gives AI tools a chance to be tested in a regulatory environment.health policyThe regulatory sandbox provides experience for refining regulation.Bipartisan US bills target AI-driven insurance claim denialsdoctorThe legislation could reduce AI-automated denials, so developments are worth following.hospital managerDenial rates and appeal burdens may change, which should be factored into revenue planning.health policyBipartisan support may signal tighter rules on insurers' use of AI.Weave Bio and Takeda deploy AI regulatory automation across 14 global programspharmaceuticalsAI automation of regulatory submission documents can speed up regulatory workflows, so a pilot is worth starting.Act XLIV of 2026 on health data management covers EESZT and refers to AIhealth ITDevelopers working with EESZT need to review the act's data management and access requirements.health policyThe act is part of the health data management framework, and its implementation is worth following.doctorThe rules on access to children's EESZT data may affect everyday practice.WHO forum: progress on health AI should be determined by strength of governancehealth policyEstablishing governance frameworks is a precondition for AI adoption.South Korea's 2027 budget plan sets aside 1.26 trillion won for regional and essential healthcare, with more medical AIhealth policyState budget priorities are shifting toward AI and care robots.medtech companyState funding for medical AI and robotics is a market opportunity.Government backs 372 AI projects in business and healthcare sectorshealth policyState AI funding could serve as a model for funding AI in healthcare.
August 2026 · 49
FDA pilot offers generative AI medical devices a path to patients before authorizationmedtech companyCompanies developing generative AI should examine whether to take part in the pilot and prepare for post-market monitoring.health policyThe regulatory approach could offer a model for other authorities handling generative AI devices.doctorUnder the pilot, devices may reach patients before authorization, so clinicians need to know a device's validation status.EU AI Act deadline for medical devices reportedly moves to 2028, with two separate deadlinesmedtech companyCompliance roadmaps need to be re-planned, and companies must clarify which deadline applies to their product.health ITSoftware should be assessed for whether it qualifies as a medical device, as that determines the deadline.health policyThe postponed deadline gives a longer transition, but institutions also need to prepare.EU court ruling clarifies medical device definition for software and AImedtech companyIntended-purpose wording and function should be reassessed, as they decide whether AI software qualifies as a device.health ITWellness and decision-support software warrants legal review.Guidelines needed as mental health practices adopt AI, reports saydoctorMental health professionals need to develop their own protocols for using AI.health policyThe lack of professional guidelines justifies regulatory action.US medical bodies: ACP issues ethics paper on AI, AMA names head of new digital health and AI centerdoctorThe ACP's ethics paper sets a professional benchmark for the use of clinical AI.UK launches £100mn competition for homegrown AI start-ups to improve the NHS and public serviceshealth ITBritish start-ups have a funding opportunity for NHS-related AI solutions.health policyThe competition is an incentive tool for AI-based public service improvement.Radiologists in Brazil debate safety rules for medical AIdoctorThe professional position of radiologists is shaping national AI safety rules.health policyThe professional debate is a factor in drawing up national regulation.FDA grants two breakthrough designations to generative AI radiology productsmedtech companyThe designation can mean expedited engagement with the FDA and is a reference point for radiology generative AI developers.doctorGenerative AI radiology tools may move closer to clinical use.Limbic selected for FDA pilot to test voice AI therapy with Medicare enrolleesdoctorMental health AI tools are entering an authorised pilot with measurable outcomes.medtech companyThe FDA pilot shows the regulatory path for mental health AI products.health policyMedicare's scope also brings the question of how AI therapy is funded to the fore.FDA updates cover substantial evidence, gene therapy and AI-enabled early-phase clinical trialspharmaceuticalsThe FDA's position on the use of AI in early-phase trials should be taken into account in development plans.AMA launches Ethical AI Use in Medicine SeriesdoctorThe series offers professional ethical guidance on the clinical use of AI.health policyThe professional body's position is a reference point in regulatory debates.Legal concerns raised over FDA's 'competency' approach to AI regulationmedtech companyGiven the legal uncertainty, compliance strategy and regulatory communication should be reviewed from a legal perspective too.health policyThe legal basis of the regulatory approach may be contested, which could affect enforceability.FDA publishes discussion paper on regulating generative AI-enabled medical devicesmedtech companyCompanies should comment on the paper, because the planned guidance will set the authorization pathway for generative AI products.health ITTeams developing or procuring software with generative functions should anticipate future FDA expectations.health policyThe public consultation offers a model for regulating fast-changing generative AI within device law.doctorThe status and evidence base of generative tools used on the client side may become clearer as a result of the regulation.WHO warns Europe's health AI governance gap may become irreversiblehealth policyNational AI governance frameworks urgently need to be put in place before the systems become widespread.hospital managerThe OPTICA evaluation framework can serve as a model for deploying AI in real-world settings.health ITSafe evaluation and deployment frameworks may become an expectation.JRC: AI can improve disease surveillance in Europe, but human oversight is essentialhealth policySurveillance AI must be designed with human oversight; EHDS data will be opened up for research and AI purposes.health ITData management must be designed to comply with the EHDS rules on secondary use of data.AI scribe risks: insurer checklist, documented errors and MHRA guidance on medical device statusdoctorGenerated notes must be checked before signing, and patient information about the tool's use must be arranged.hospital managerLiability and risk management must be clarified in contracts with scribe vendors.health ITAccording to the MHRA, the line between administrative AI and a medical device must be watched in contracts and marketing as well.FDA clears two AI tools: pulmonary hypertension detection from ECGs and sepsis predictiondoctorNew early-warning tools are becoming available based on routine tests (ECG) and clinical data.hospital managerDeploying sepsis prediction brings measurable outcomes as well as an alert burden.medtech companyCleared examples provide a reference for AI-based early-warning products.Israel's regulatory sandbox tests autonomous AI in clinical carehealth policyThe sandbox is a model for gaining regulatory experience in a controlled setting.medtech companyIt offers a testing opportunity for autonomous AI tools.Radiology Partners unit Mosaic petitions FDA on imaging AI regulationdoctorRadiologists should follow the petition, as rules on oversight of imaging AI may affect everyday use of the tools.medtech companyThe petition may affect the regulatory environment for imaging AI manufacturers.Gap between state and territorial AI policies and public health practicehealth policyState AI rules need to be aligned with public health practice.FDA discussion paper would assess generative AI devices in a way similar to doctorsmedtech companyDuring the comment period, companies should indicate which tier of the proposed graduated assessment their product would fall into and what evidence they can provide for it.doctorThrough professional organizations, physicians can have a say in what clinical confirmation generative AI tools should be required to show.health ITTeams need to assess which embedded generative functions could fall under device regulation.health policyThe FDA is signaling a direction for authorizing generative AI, which may serve as a benchmark for other regulators.FDA has authorized more than 1,500 AI devices, but evidence is laggingdoctorAuthorized status alone does not indicate clinical benefit, so the validation behind a purchased device should be asked about separately.hospital managerIn procurement, local or prospective evidence should be requested from the vendor; the FDA list alone is not enough.medtech companyGiven the evidence gap, companies should expect stronger demands for clinical substantiation.FDA's predetermined change control plan (PCCP) may play a growing role for AI devicesmedtech companyScheduled, pre-approved frameworks for model updates should already be planned at the time of submission.health ITVendors should be asked for the change limits set out in their PCCP, so it is clear what can be updated without separate authorization.Regulating AI therapists: California lawmakers and the limits of unauthorized-practice rulesdoctorPsychiatrists and therapists should track which tools are classified as therapeutic activity.health policyA ban on unauthorized practice does not on its own cover mental health chatbots, so a targeted rule is needed.health ITCompanies building mental health chatbots must expect requirements that differ from state to state.EU AI Act high-risk deadline pushed back 16 months; Health Canada clarifies status of AI scribesmedtech companyClassification under Annex I and Annex III must be re-planned around the new deadlines.health ITScribe products require a separate legal classification review.CureMetrix receives FDA 510(k) clearance for cmAngio 2.0doctorA new cleared AI tool is available in imaging diagnostics.medtech companyClearance of a version update points to a direction of rapid iteration.AI-driven healthcare fraud and False Claims Act liabilityhospital managerAI-based coding and billing require compliance review.AI literacy in healthcare: why it mattershospital managerTraining in AI literacy across the institution is worth planning.With no uniform rules, liability for healthcare AI errors remains unclearhospital managerAI procurement contracts should set out the sharing of liability with the vendor separately.doctorIt needs to be clarified what liability follows from following or rejecting an AI recommendation.medtech companyUnclear liability creates contractual and insurance risk for distributors.CHAI launches new health AI cybersecurity work grouphealth ITThe work group's output is worth following to prepare for security requirements for AI systems.hospital managerCybersecurity assessment becomes one of the decision criteria in AI procurement.Leica Biosystems receives FDA clearances for AI-assisted quality control and digital pathology scannersdoctorPathologists gain a wider range of FDA-cleared digital workflow tools.hospital managerA new cleared option is available when planning digital pathology investments.medtech companyCleared AI quality control sets a competitive benchmark in the pathology scanner market.Roen Surgical wins first FDA clearance for an AI-guided kidney stone robotdoctorFDA-cleared AI robotics is appearing in urological procedures.medtech companyThe first clearance sets a precedent for the regulatory pathway of surgical AI robots.Seven US states passed healthcare AI rules in 2026, mainly on prior authorizationdoctorIt is worth tracking which states require human review, as this matters when appealing denials.hospital managerPatient care and billing processes must be aligned with state requirements.health policyRegulatory fragmentation across states strengthens the case for federal-level harmonisation.California bill would ban AI therapists as states weigh regulating mental health chatbotsdoctorPsychiatric and therapy providers need to watch which AI functions will be allowed to count as therapy.health ITThe marketing and features of mental health chatbots must be aligned with the legal limits.health policyState regulation may fill a gap left by the absence of federal rules.Some EU AI Act deadlines for healthcare AI and medical devices pushed back to 2028medtech companyCompanies need to assess which AI Act obligations already apply, which are postponed, and which relief measures have not been used.health ITFor software classed as a medical device, the classification (SaMD/MDR) must be reviewed again because of AI functions.health policyThe postponement gives authorities transitional time to prepare and to develop guidelines.FDA clears Ceribell's AI enhancements and outlines expectations for AI heart-monitoring wearablesmedtech companyDevelopers of wearable heart monitors should compare their product documentation with the expectations the FDA has set out.doctorNeurological and cardiac monitoring extended with AI can rely on cleared devices.FDA advisory committee to review GRAIL's Galleri multi-cancer early detection testdoctorThe authorization decision on multi-cancer screening tests may shape screening recommendations and patient information.medtech companyThe Galleri review is a precedent for the PMA pathway of similar AI-driven diagnostic tests.Netcare submits AI clinical algorithm for approvalhospital managerA hospital group seeking approval for its own AI algorithm signals that in-house developments are also entering the regulatory pathway.Ghana's health ministry develops AI policy for safe use in healthcarehealth policyA national AI policy in health offers an example of how to build safety frameworks.FDA's draft MDUFA VI commitment letter has implications for AI and digital healthmedtech companyCommitments tied to the user-fee cycle may affect the pace of review for AI-enabled devices, so the draft is worth reviewing.health policyThe draft shapes the regulatory framework for device authorization.EU AI Omnibus now in force: AI requirements for medical devices postponed to 2 August 2028medtech companyThe compliance deadline for AI devices is 2 August 2028, so companies should also plan for the notified bodies' 28 January 2028 deadline in coordination with their certification body.health policyMedical AI counts as high-risk via the Annex I route, so preparation should build on the existing MDR certification structure.California bill would restrict AI chatbots in mental health treatmentdoctorFor psychiatrists and psychologists, it could set a legal framework for when a chatbot may be recommended as a supplement to therapy.health ITCompanies offering mental health chatbots would have to adapt their products to the proposed ban and restrictions.health policyState-level action points to a gap in federal regulation.Insilico Medicine gets China IND approval for AI-discovered Parkinson's drug candidate, launches benchmarkpharmaceuticalsAn AI-designed candidate entering human clinical trials, along with a model benchmark, also offers a reference point for evaluating research tools.London launches AI health regulatory sandbox for NHS innovation, MHRA seeks applicantsmedtech companyAI developers can apply to the MHRA sandbox for assessment before NHS deployment.health policyThe sandbox model offers a template for bridging the gap between approval and deployment.Colorado law setting guardrails for AI in healthcare takes effecthospital managerColorado institutions must review their AI use practices in line with the law's requirements.health ITVendors of AI solutions must check compliance with the requirements.FDA actions on AI tools: breast ultrasound, intraoperative margins, hidden heart disease, Aidoc First ReaddoctorNew FDA-cleared AI tools are entering radiology and surgical practice.medtech companyThe clearance patterns offer guidance on the FDA pathway for similar AI tools.FDA's July non-device software update and TEMPO AI pilot draw analysismedtech companyThe device or non-device classification of AI apps needs to be reassessed in light of the FDA update.Indiana HB 1271 would ban AI downcoding of dental claims; Illinois would require disclosurehospital managerIn billing and appeals, flag suspected AI-based downcoding to insurers.Federation of State Medical Boards: generative medical AI should not be licensed to practice on its owndoctorAI should continue to be treated as a tool, with responsibility remaining with the physician.health policyIndividual physician licensing is not the model to follow for regulating AI.